** = Publikationen gelistet in SCI/SSCI/Pubmed
** Clodi, M; Toplak, H; Resl, M; Brix, J; Leitner, DR; Harreiter, J; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B
[Obesity and type 2 diabetes (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 91-97.
Doi: 10.1007/s00508-023-02184-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Metzner, T; Leitner, DR; Dimsity, G; Gunzer, F; Opriessnig, P; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Deutschmann, H; März, W; Landmesser, U; Brodmann, M; Reishofer, G; Scharnagl, H; Toplak, H; Silbernagel, G
Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study.
Biomedicines. 2022; 10(1):
Doi: 10.3390/biomedicines10010152
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Metzner, T; Leitner, DR; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Reishofer, G; März, W; Landmesser, U; Scharnagl, H; Toplak, H; Silbernagel, G
Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study.
Biomedicines. 2022; 10(1):
Doi: 10.3390/biomedicines10010193
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Metzner, T; Leitner, DR; Dimsity, G; Gunzer, F; Opriessnig, P; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Deutschmann, H; Arz, WM; Landmesser, U; Brodmann, M; Reishofer, G; Scharnagl, H; Toplak, H; Silbernagel, G
SHORT-TERM EFFECTS OF INTENSIVE LDL-CHOLESTEROL LOWERING WITH ALIROCUMAB ON VASCULAR STRUCTURE AND FUNCTION
ATHEROSCLEROSIS. 2021; 331: E228-E228.
[Poster]
Web of Science
** Leitner, DR; Toplak, H; Kedenko, L; Steinmaurer, T; Gräff, V; Metzner, T; Schwaiger, EM; Prager, R
Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study.
Curr Med Res Opin. 2020; 1-1.
Doi: 10.1080/03007995.2020.1786678
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zingl, FG; Kohl, P; Cakar, F; Leitner, DR; Mitterer, F; Bonnington, KE; Rechberger, GN; Kuehn, MJ; Guan, Z; Reidl, J; Schild, S
Outer Membrane Vesiculation Facilitates Surface Exchange and In Vivo Adaptation of Vibrio cholerae.
Cell Host Microbe. 2020; 27(2):225-237
Doi: 10.1016/j.chom.2019.12.002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vorkapic, D; Mitterer, F; Pressler, K; Leitner, DR; Anonsen, JH; Liesinger, L; Mauerhofer, LM; Kuehnast, T; Toeglhofer, M; Schulze, A; Zingl, FG; Feldman, MF; Reidl, J; Birner-Gruenberger, R; Koomey, M; Schild, S
A Broad Spectrum Protein Glycosylation System Influences Type II Protein Secretion and Associated Phenotypes in Vibrio cholerae.
Front Microbiol. 2019; 10:2780
Doi: 10.3389/fmicb.2019.02780
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Toplak, H; Leitner, DR; Harreiter, J; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B
["Diabesity"-Obesity and type 2 diabetes (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):71-76
Doi: 10.1007/s00508-018-1418-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Busetto, L; Dicker, D; Azran, C; Batterham, RL; Farpour-Lambert, N; Fried, M; Hjelmesæth, J; Kinzl, J; Leitner, DR; Makaronidis, JM; Schindler, K; Toplak, H; Yumuk, V
Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management".
Obes Surg. 2018; 28(7):2117-2121
Doi: 10.1007/s11695-018-3283-z
Web of Science
PubMed
FullText
FullText_MUG
** Kotsis, V; Jordan, J; Micic, D; Finer, N; Leitner, DR; Toplak, H; Tokgozoglu, L; Athyros, V; Elisaf, M; Filippatos, TD; Redon, J; Redon, P; Antza, C; Tsioufis, K; Grassi, G; Seravalle, G; Coca, A; Sierra, C; Lurbe, E; Stabouli, S; Jelakovic, B; Nilsson, PM
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment.
J Hypertens. 2018; 36(7):1427-1440
Doi: 10.1097/HJH.0000000000001730
Web of Science
PubMed
FullText
FullText_MUG
** Kotsis, V; Tsioufis, K; Antza, C; Seravalle, G; Coca, A; Sierra, C; Lurbe, E; Stabouli, S; Jelakovic, B; Redon, J; Redon, P; Nilsson, PM; Jordan, J; Micic, D; Finer, N; Leitner, DR; Toplak, H; Tokgozoglu, L; Athyros, V; Elisaf, M; Filippatos, TD; Grassi, G
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions.
J Hypertens. 2018; 36(7):1441-1455
Doi: 10.1097/HJH.0000000000001731
Web of Science
PubMed
FullText
FullText_MUG
** Busetto, L; Dicker, D; Azran, C; Batterham, RL; Farpour-Lambert, N; Fried, M; Hjelmesæth, J; Kinzl, J; Leitner, DR; Makaronidis, JM; Schindler, K; Toplak, H; Yumuk, V
Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management.
Obes Facts. 2017; 10(6):597-632
Doi: 10.1159/000481825
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leitner, DR; Frühbeck, G; Yumuk, V; Schindler, K; Micic, D; Woodward, E; Toplak, H
Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way.
Obes Facts. 2017; 10(5):483-492
Doi: 10.1159/000480525
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leitner, DR; Lichtenegger, S; Temel, P; Zingl, FG; Ratzberger, D; Roier, S; Schild-Prüfert, K; Feichter, S; Reidl, J; Schild, S
A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles.
Front Microbiol. 2015; 6(137):823-823
Doi: 10.3389/fmicb.2015.00823
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Salem, W; Leitner, DR; Zingl, FG; Schratter, G; Prassl, R; Goessler, W; Reidl, J; Schild, S
Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coli.
Int J Med Microbiol. 2015; 305(1):85-95
Doi: 10.1016/j.ijmm.2014.11.005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Seper, A; Pressler, K; Kariisa, A; Haid, AG; Roier, S; Leitner, DR; Reidl, J; Tamayo, R; Schild, S
Identification of genes induced in Vibrio cholerae in a dynamic biofilm system.
Int J Med Microbiol. 2014; 304(5-6): 749-763.
Doi: 10.1016/j.ijmm.2014.05.011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leitner, DR; Feichter, S; Schild-Prüfert, K; Rechberger, GN; Reidl, J; Schild, S
Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.
Infect Immun. 2013; 81(7): 2379-2393.
Doi: 10.1128/IAI.01382-12
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Roier, S; Fenninger, JC; Leitner, DR; Rechberger, GN; Reidl, J; Schild, S
Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.
Int J Med Microbiol. 2013; 303(5): 247-256.
Doi: 10.1016/j.ijmm.2013.05.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Seper, A; Hosseinzadeh, A; Gorkiewicz, G; Lichtenegger, S; Roier, S; Leitner, DR; Röhm, M; Grutsch, A; Reidl, J; Urban, CF; Schild, S
Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases.
PLoS Pathog. 2013; 9(9):e1003614-e1003614
Doi: 10.1371/journal.ppat.1003614
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Roier, S; Leitner, DR; Iwashkiw, J; Schild-Prüfert, K; Feldman, MF; Krohne, G; Reidl, J; Schild, S
Intranasal immunization with nontypeable Haemophilus influenzae outer membrane vesicles induces cross-protective immunity in mice.
PLoS One. 2012; 7(8): e42664-e42664.
Doi: 10.1371/journal.pone.0042664
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG